PD-L1 and LAG3 Expression in Hepatocellular Carcinoma Associated with HCV and Steatohepatitis

被引：0
|
作者：
Xing, Dongmei
Luan, Lan
Zhu, Qingfeng
Gani, Faiz
Pawlik, Timothy
Taube, Janis M.
Anders, Robert A.
机构：
[1] Weill Cornell Med, New York, NY USA
[2] Johns Hopkins Univ, Baltimore, MD USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1707
引用
收藏
页码：426A / 426A
页数：1
相关论文
共 50 条
  • [31] Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma
    Zhao, Tiesuo
    Wei, Pengkun
    Zhang, Congli
    Zhou, Shijie
    Liang, Lirui
    Guo, Shuoshuo
    Yin, Zhinan
    Cheng, Sichang
    Gan, Zerui
    Xia, Yuanling
    Zhang, Yongxi
    Guo, Sheng
    Zhong, Jiateng
    Yang, Zishan
    Tu, Fei
    Wang, Qianqing
    Bai, Jin
    Ren, Feng
    Feng, Zhiwei
    Jia, Huijie
    ELIFE, 2024, 12
  • [32] EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
    Xiao, Gang
    Jin, Li-Lian
    Liu, Chao-Qun
    Wang, Yong-Chun
    Meng, Ya-Ming
    Zhou, Zhong-Guo
    Chen, Jing
    Yu, Xing-Juan
    Zhang, Yao-Jun
    Xu, Jing
    Zheng, Limin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [33] Multiplex immunohistochemistry analysis of CTLA4, PD-L1, LAG3 and tumour microenvironment components in relation to MMR status in colorectal carcinoma
    Naumov, S.
    Krakhmal, N.
    Vtorushin, S.
    VIRCHOWS ARCHIV, 2024, 485 : S157 - S158
  • [34] PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival
    Micevic, Goran
    Thakral, Durga
    McGeary, Meaghan
    Bosenberg, Marcus W.
    PIGMENT CELL & MELANOMA RESEARCH, 2019, 32 (03) : 435 - 440
  • [35] Prognostic Value of PD-L1 in Patients with Hepatocellular Carcinoma
    Pei, Renguang
    Zhang, Weixuan
    Wang, Sufen
    Huang, Xi
    Zou, Yinghua
    CLINICAL LABORATORY, 2019, 65 (05) : 693 - 698
  • [36] Soluble PD-L1 and prognosis of patients with hepatocellular carcinoma
    Luo, Cheng-Piao
    Mo, Han-Yue
    Wu, Ling-Ling
    Ma, Yun
    Peng, Ning-Fu
    EUROPEAN JOURNAL OF CANCER, 2017, 71 : 117 - 118
  • [37] LAG3 transcriptomic expression correlates with high levels of PD-1, PD-L1, PD-L2, and CTLA-4 checkpoints and with high tumor mutational burden across cancers
    Adashek, Jacob J.
    Kato, Shumei
    Pabla, Sarabjot
    Nesline, Mary
    Conroy, Jeffrey M.
    Subbiah, Vivek
    DePietro, Paul
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] PD-L1 Expression is Associated With Poor Prognosis in Renal Cell Carcinoma
    Carlsson, Jessica
    Sundqvist, Pernilla
    Kosuta, Vezira
    Falt, Anna
    Giunchi, Francesca
    Fiorentino, Michelangelo
    Davidsson, Sabina
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (03) : 213 - 220
  • [39] Correlation of PD-L1 and SOCS3 Co-expression with the Prognosis of Hepatocellular Carcinoma Patients
    Chen, Liuxi
    Huang, Xingxing
    Zhang, Wenzheng
    Liu, Ying
    Chen, Bi
    Xiang, Yu
    Zhang, Ruonan
    Zhang, Mingming
    Feng, Jiao
    Liu, Shuiping
    Duan, Ting
    Chen, Xiaying
    Wang, Wengang
    Pan, Ting
    Yan, Lili
    Jin, Ting
    Li, Guohua
    Li, Yongqiang
    Xie, Tian
    Sui, Xinbing
    JOURNAL OF CANCER, 2020, 11 (18): : 5440 - 5448
  • [40] PD-L1 is Fascinating but IDO Needs Attention in Non-HCV and Non-HBV-Associated Hepatocellular Carcinoma Patients
    Asghar, Kashif
    Bashir, Shaarif
    Rana, Iftikhar Ali
    Abu Bakar, Muhammad
    Farooq, Asim
    Hassan, Muhammad
    Asif, Zukhruf
    Afzal, Mahnoor
    Masood, Iqra
    Ishaq, Muhammad
    Tahseen, Muhammad
    Bilal, Sundus
    Mehmood, Shafqat
    Kanwal, Nosheen
    Din, Islah Ud
    Loya, Asif
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 921 - 934
12345